日本食品補充品 - 2024-2027

報告概述

日本食品補充劑市場在2023年達到171.2179億美元，預計到2027年將達到234.8673億美元，2024-2027年預測期間複合年成長率為8.49%。

日本消費者對支持特定健康益處的產品表現出強烈的偏好。這包括針對免疫支持、消化健康和認知功能的補充劑。美容補充劑也很受歡迎，專注於增強皮膚健康和頭髮生長，反映了日本強勁的美容和個人護理行業。

日本膳食補充劑的監管架構非常嚴格，強調產品的安全性和功效。產品必須經過嚴格的測試並獲得厚生勞動省 (MHLW) 或消費者事務局 (CAA) 等當局的批准。為了確保透明度和消費者信任，必須遵守標籤法規。

膳食補充劑主要透過藥局、藥局、保健食品店和超市等既定管道銷售。電子商務平台的興起進一步擴大了准入範圍，為全國消費者提供了便利和廣泛的產品範圍。

日本錯綜複雜的監管環境給尋求市場進入的新進入者帶來了挑戰。然而，創新機會比比皆是，特別是在開發解決特定健康問題或利用獨特成分的產品方面。電子商務的成長提供了另一種擴張途徑，可實現直接面對消費者的銷售和個人化行銷策略。

日本食品補充劑市場不斷發展，重點關注健康、保健和監管合規性。了解和適應消費者偏好，再加上監管要求，對於這個充滿活力的行業的持續成長和成功至關重要。

市場促進因素

營養缺乏症的增加

日本傳統飲食歷來強調魚、米、蔬菜以及味噌和醬油等發酵食品，但現在正擴大被富含加工食品、糖和脂肪的西化飲食所取代。這些飲食習慣的改變可能會導致營養攝取失衡，導致維生素、礦物質和必需脂肪酸的缺乏。

儘管日本以健康的飲食習慣而聞名，但個人的飲食多樣性可能有限。有些人可能沒有攝取足夠的水果、蔬菜和全穀物，這些是維生素、礦物質和膳食纖維的重要來源。因此，營養缺乏症的增加促進了市場的成長。

例如，《2022 年全球營養報告》指出，日本在實現與飲食相關的非傳染性疾病 (NCD) 目標方面取得的進展有限。 4.3% 的成年女性（18 歲及以上）和 6.0% 的成年男性患有肥胖症。日本的肥胖率低於地區平均（女性為 10.3%，男性為 7.5%）。就成年女性而言，該國「正在」實現糖尿病目標（5.0%受影響），但就成年男性而言，該國「偏離」了糖尿病目標（9.1%受影響）。

此外，快速的城市化和忙碌的生活方式往往導致不規則的飲食模式和對簡便食品的依賴，而這些食品可能缺乏足夠的營養價值。補充劑提供了一種實用的解決方案，可確保在繁忙的日程和飲食挑戰中攝取必需的營養。這種趨勢在便利性與健康意識交叉的日本城市居民中尤其普遍。

科學、技術、消費者教育和監管支持的進步進一步推動了市場的成長，這些進步共同提高了膳食補充劑的可及性、安全性和有效性。

公司採取的策略

與零售連鎖店、藥局、保健食品店和電子商務平台合作，擴大市場範圍並提高產品的可及性。與醫療保健專業人員、健康中心或企業健康計劃的策略合作夥伴關係也有利於產品推薦和分銷。

例如，2021年，凱愛瑞與Pharma Foods International Co. Ltd.（PFI）合作，針對功能性食品飲料和膳食補充劑聯合健康成分技術進行開發、應用和全球銷售。 Pharma Foods International 總部位於日本京都，是利用天然食品來源開發創新成分並將其應用於功能性產品、營養保健品、化妝品和藥品的先驅和領導者。

此外，2022 年，麒麟控股將擴大其功能性食品產品陣容，以增強日本的免疫保健能力。麒麟控股將與外部合作夥伴公司合作，增加免疫功能聲稱和含有其獨家後生元乳酸乳球菌菌株的產品數量。補充劑。

此外，2023年，日本製藥商大塚製藥以4.25億美元收購了美國女性保健食品公司Bonafide Health及其母公司大塚控股，以使其女性補充劑產品組合多元化。透過本次收購，大塚製藥不斷拓展女性保健品等領域的業務。這些策略共同推動了在日本食品補充劑市場中營運的公司的成長、擴大市場佔有率並保持競爭優勢。

市場限制

感知過度消費風險

日本消費者經常向醫生和藥劑師等醫療保健專業人士諮詢健康建議和建議。醫療專業人員可能會警告不要過度使用補充劑，並強調從均衡飲食和生活方式中獲取營養的重要性。該建議可能會影響消費者對補充劑使用的看法和決定。

一些消費者和醫療保健專業人士擔心過度消耗補充劑中某些營養素的潛在風險，這可能會導致不良健康影響。這種謹慎可能會影響消費者的行為和使用模式。例如，2024年，一直銷售膳食補充劑和非處方藥的小林製藥在引起擔憂後召回了該產品。

日本在全國範圍內召回了一種旨在降低膽固醇水平的膳食補充劑，有人猜測該補充劑可能導致該國兩人死亡和約 106 人住院。該公司召回了五種產品，其中包括約 30 萬單位的“紅麴膽固醇幫助”，該產品以幫助降低膽固醇而聞名。

此外，過度消費的感知風險透過影響消費者態度、監管政策、醫療保健建議和市場動態來限制日本的食品補充劑市場。克服這些挑戰需要透過教育、透明度和遵守嚴格的安全標準來建立消費者信任，同時強調補充劑在支持整體健康和福祉以及均衡飲食方面的補充作用。因此，上述因素抑制了市場的成長。

細分市場分析

日本食品補充劑市場根據成分、劑量、應用、年齡和配銷通路進行細分。

抗衰老/健康衰老的需求不斷成長推動了該細分市場的成長

預計在 2024 年至 2027 年預測期內，抗衰老/健康老化領域將佔據超過 11.29% 的市場佔有率。抗衰老/健康老化領域在日本食品補充劑市場中佔據主導地位，這主要是由於該國人口迅速老化以及對長壽和健康的文化關注。

日本是世界上人口老化程度最高的國家之一。這種人口結構的變化推動了對促進健康老化的補充劑的需求，包括支持關節健康、認知功能和骨骼強度的產品。例如，根據總務省公佈的數據，日本65歲及以上老年人的比例也創歷史新高，佔總人口的29.1%，為世界最高比例。

日本的醫療保健系統提倡定期健康檢查和預防保健，這鼓勵老年人積極尋求補充劑來管理與年齡相關的疾病。用於心臟健康的 omega-3 脂肪酸和用於腸道健康的益生菌等產品因其預防功效而被廣泛消費。

許多大公司都專注於抗衰老領域，在日本推出創新補充劑。例如，2024 年 1 月，資生堂中國業務創新與投資高級副總裁表示，他們將於 2024 年在日本和中國推出一套新的由內而外美容補充劑，以安瓿飲料的形式推出。這一消息。

永續性分析

在消費者對環保實踐的需求、監管壓力和企業責任的推動下，日本食品補充劑市場的永續性變得越來越重要。日本消費者越來越青睞由天然有機成分製成的補充品。這與日本對自然更廣泛的文化敬畏相一致，這反映在植物性補充劑（如綠茶或海藻提取物）的日益流行上。

許多日本補充劑公司正在採用環保包裝解決方案，減少塑膠的使用並選擇可生物分解的材料。例如，FANCL Corporation 為其部分補充劑系列引入了可回收包裝。 FANCL回收計劃是一項從全國商店的顧客那裡收集用過的容器的計劃。這些容器由特殊子公司FANCL SMILE進行分類、清潔、乾燥和粉碎，然後由合作夥伴回收公司利用材料回收技術回收製成花盆。

此外，大塚製藥等公司正在採取措施，透過在生產過程中使用再生能源和最佳化供應鏈物流來減少碳足跡，以盡量減少對環境的影響。

日本政府鼓勵跨產業的永續實踐。促進減少排放、廢棄物管理和永續農業的政策的推出直接影響補充劑製造商，推動他們採用更綠色的生產方法。日本擴大支持循環經濟實踐，其中涉及供應鏈內的材料回收和再利用。

未滿足的需求

消費者對補充劑的信任取決於透明且基於證據的健康聲明。儘管有嚴格的監管框架，但仍需要更強力的臨床試驗和研究來驗證補充劑成分的功效和安全性。這一差距為公司提供了投資嚴格科學研究以證實健康主張的機會，特別是對於植物萃取物和新穎配方等新興成分。

隨著消費者對環境永續性和道德採購實踐的認知不斷增強，對源自永續來源成分的補充劑的需求不斷成長。品牌有機會透過採用透明的供應鏈實踐、環保包裝和支持道德農業實踐來使自己脫穎而出。解決這些問題可以提高品牌信譽並吸引有環保意識的消費者。

隨著消費者對壓力管理、免疫支持和消化健康等特定健康問題的認知不斷提高，補充劑有機會提供有針對性的健康解決方案，並具有明顯的好處。成分組合和輸送系統的創新可以解決這些未滿足的需求，為常見的健康挑戰提供有效且經過科學驗證的解決方案。

儘管補充劑隨處可見，但仍需要營養豐富的製劑，以方便的形式提供全面的營養支持。以均衡比例結合維生素、礦物質、抗氧化劑和植物營養素的產品可以滿足整體健康解決方案的需求，滿足忙碌的生活方式和多樣化的飲食偏好。

市場競爭格局

日本市場的主要全球參與者包括四葉日本、DHC Corporation、Yazuya Co. Ltd.、Asahi Group Foods, Ltd.、FANCL Corporation、YUWA CO., LTD.、Meiji Holdings Co., Ltd.、MORINAGA MILK INDUSTRY CO . ., LTD.、Nihon kefir Co., Ltd.、ORIHIRO Co., Ltd. 等。

按成分

維生素

植物藥

礦物質

蛋白質和胺基酸

歐米伽脂肪酸

益生菌

其他

按劑量

藥片

膠囊

液體

粉末

咀嚼片和軟糖

軟膠囊

其他

按申請

腸胃健康

腸道微生物群/微生物組平衡

消化

便秘

腹脹

腹瀉

腸漏

發炎

其他

麩質敏感性

腹痛

胃食道逆流症/幽門螺旋桿菌

抗生素相關腹瀉/抗生素後治療

腸道菌叢/腸道微生物組恢復

其他

陰道健康

泌尿道健康

腎結石

泌尿道感染

其他

口腔健康

抗/健康老化

過敏/氣喘

骨骼與關節健康

骨關節炎

骨質疏鬆症/礦物質骨密度低

發炎

大腦/心理健康

睡覺

認知

情緒

沮喪

重點

心血管健康

循環

減少能量/疲勞

代謝症候群/血糖

肝臟健康

活力

免疫/呼吸道感染

營養吸收

皮膚-頭髮-指甲

異位性皮膚炎和濕疹

粉刺

酒渣

頭髮生長/掉髮

皮膚微生物群

其他

運動的

女性健康

生育能力

停經

懷孕

多囊性卵巢症候群

陰道健康與健康 陰道微生物組

陰道感染 (BV/VVC)

懷孕結果

其他

男性健康與男性生育能力

體重管理

兒科健康

絞痛

便秘

逆流

異位性皮膚炎

其他

其他

按年齡

嬰兒

孩子們

成年人

老年人

按配銷通路

超市/大賣場

藥局和藥局

便利商店

網路零售商

其他分銷管道

主要進展

2024 年5 月，日本健康公司Natural Tech Co Ltd 在「需求激增」的情況下發布了一款新的眼部補充劑，並表示現代消費者生活方式的變化和日本人口老化導致與眼睛相關的問題日益增多，該公司旨在透過其產品來解決這一問題。

2023 年 5 月，日本公司 DyDo DRINCO 打算進一步深入研究針對老年人群的健康食品類別，推出其聲稱有助於減輕眼睛疲勞和改善睡眠品質的雙效補充劑。

2021 年 7 月，味之素在一項臨床試驗的支持下推出了一款補充劑，旨在降低健康中年人和患有某種形式記憶障礙的老年人認知能力下降的風險。

2021 年 11 月，大塚製藥有限公司推出了 tocoelle，這是一種為受經前波動困擾的女性提供支持的補充劑。此補充劑提供四種重要成分：大豆油中含有的維生素 E（Y-生育酚和 Y-生育三烯酚）；雌馬酚，由大豆異黃酮製成；以及鈣，一種日常飲食中常缺乏的礦物質。

為什麼購買報告？

根據成分、劑量、應用、年齡和配銷通路可視化日本食品補充劑市場細分，並了解關鍵商業資產和參與者。

透過分析趨勢和共同開發來識別商業機會。

Excel資料表，包含日本食品補充品市場所有細分市場的大量資料點。

PDF 報告由詳盡的質性訪談和深入研究後的綜合分析組成。

產品映射以 Excel 形式提供，包含所有主要參與者的關鍵產品。

日本食品補充劑市場報告將提供約 45 個表格、62 個圖表和 204 頁。

2024 年目標受眾

製造商/買家

產業投資者/投資銀行家

研究專業人員

新興公司

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

• 影響因素
  • 促進要素
    • 營養缺乏症的增加
    • 公司採取的策略
  • 限制
    • 感知過度消費風險
  • 機會
  • 影響分析

第 5 章：產業分析

• 波特五力分析
• 供應鏈分析
• 定價分析
• 監管分析
• DMI 意見

第 6 章：按成分

• 維生素
• 植物藥
• 礦物質
• 蛋白質和胺基酸
• 歐米伽脂肪酸
• 益生菌
• 其他

第 7 章：按劑量

• 藥片
• 膠囊
• 液體
• 粉末
• 其他

第 8 章：應用

• 腸胃健康
  • 腸道微生物群/微生物組平衡
  • 消化
  • 便秘
  • 腹脹
  • 腹瀉
  • 腸漏
  • 發炎
  • 其他
    • 麩質敏感性
    • 腹痛
    • 胃食道逆流症/幽門螺旋桿菌
    • 抗生素相關腹瀉/抗生素後治療
    • 腸道菌叢/腸道微生物組恢復
    • 其他
• 陰道健康
• 泌尿道健康
  • 腎結石
  • 泌尿道感染
  • 其他
• 口腔健康
• 抗/健康老化
• 過敏/氣喘
• 骨骼與關節健康
  • 骨關節炎
  • 骨質疏鬆症/礦物質骨密度低
  • 發炎
• 大腦/心理健康
  • 睡覺
  • 認知
  • 情緒
  • 沮喪
  • 重點
• 心血管健康
• 循環
• 減少能量/疲勞
• 代謝症候群/血糖
• 肝臟健康
• 能源
• 免疫/呼吸道感染
• 營養吸收
• 皮膚-頭髮-指甲
  • 異位性皮膚炎和濕疹
  • 粉刺
  • 酒渣
  • 頭髮生長/掉髮
  • 皮膚微生物群
  • 其他
• 運動的
• 女性健康
  • 生育能力
  • 停經
  • 懷孕
  • 多囊性卵巢症候群
  • 陰道健康與健康 陰道微生物組
  • 陰道感染 (BV/VVC)
  • 懷孕結果
  • 其他
• 男性健康與男性生育能力
• 體重管理
• 兒科健康
  • 絞痛
  • 便秘
  • 逆流
  • 異位性皮膚炎
  • 其他
• 其他

第9章：年齡

• 嬰兒
• 孩子們
• 成年人
• 老年人

第 10 章：配銷通路

• 超市/大賣場
• 藥局和藥局
• 便利商店
• 網路零售商
• 其他分銷管道

第 11 章：永續性分析

• 環境分析
• 經濟分析
• 治理分析

第 12 章：競爭格局

• 競爭場景
• 市場定位/佔有率分析
• 併購分析

第 13 章：公司簡介

• Yotsuba Japan
• 公司概況
• 類型組合和描述
• 財務概覽
• 主要進展
• DHC Corporation
• Yazuya Co. Ltd.
• Asahi Group Foods, Ltd.
• FANCL Corporation
• YUWA CO., LTD.
• Meiji Holdings Co., Ltd.
• MORINAGA MILK INDUSTRY CO., LTD.
• Nihon kefir Co., Ltd.
• ORIHIRO Co., Ltd. (*LIST NOT EXHAUSTIVE)

第 14 章：附錄

Report Overview

Japan Food Supplement Market reached US$ 17,121.79 million in 2023 and is expected to reach US$ 23,486.73 million by 2027, growing with a CAGR of 8.49% during the forecast period 2024-2027.

Japanese consumers exhibit a strong preference for products that support specific health benefits. This includes supplements targeting immune support, digestive health and cognitive function. Beauty supplements are also popular, focusing on enhancing skin health and hair growth, reflecting Japan's robust beauty and personal care industry.

The regulatory framework governing dietary supplements in Japan is stringent, emphasizing product safety and efficacy. Products must undergo rigorous testing and receive approval from authorities such as the Ministry of Health, Labour and Welfare (MHLW) or the Consumer Affairs Agency (CAA). Compliance with labeling regulations is mandatory to ensure transparency and consumer trust.

Dietary supplements are predominantly sold through established channels such as pharmacies, drugstores, health food stores and supermarkets. The rise of e-commerce platforms has further expanded access, offering convenience and a wide product range to consumers nationwide.

Navigating Japan's intricate regulatory landscape poses challenges for new entrants seeking market entry. However, opportunities abound for innovation, particularly in developing products that address specific health concerns or leverage unique ingredients. E-commerce growth presents another avenue for expansion, enabling direct-to-consumer sales and personalized marketing strategies.

The Japanese food supplement market continues to evolve with a focus on health, wellness and regulatory compliance. Understanding and adapting to consumer preferences, coupled with navigating regulatory requirements, are crucial for sustained growth and success in this dynamic sector.

Market Drivers

The Rise of Nutritional Deficiencies

Traditional Japanese diets, which historically emphasized fish, rice, vegetables and fermented foods like miso and soy sauce, are being increasingly replaced by more Westernized diets high in processed foods, sugars and fats. These dietary shifts may contribute to imbalances in nutrient intake, leading to deficiencies in vitamins, minerals and essential fatty acids.

Despite Japan's reputation for healthy eating habits, dietary diversity among individuals may be limited. Some people may not consume enough fruits, vegetables and whole grains, which are important sources of vitamins, minerals and dietary fiber. Thus rise of nutritional deficiencies boosts market growth.

For instance, the Global Nutrition Report, 2022, stated that Japan has shown limited progress towards achieving the diet-related non-communicable disease (NCD) targets. 4.3% of adult (aged 18 years and over) women and 6.0% of adult men are living with obesity. Japan's obesity prevalence is lower than the regional average of 10.3% for women and 7.5% for men. The country is 'on course' to meet the target for diabetes when looking at adult women (5.0% affected), but they are 'off course' to meet the target for diabetes when looking at adult men (9.1% affected).

Moreover, the rapid urbanization and hectic lifestyles often lead to irregular eating patterns and reliance on convenience foods, which may lack adequate nutritional value. Supplements offer a practical solution to ensure essential nutrient intake amidst busy schedules and dietary challenges. This trend is particularly prevalent among urban dwellers in Japan, where convenience and health consciousness intersect.

The market's growth is further propelled by advancements in science, technology, consumer education and regulatory support that collectively enhance the accessibility, safety and effectiveness of dietary supplements.

Strategies Adopted by the Companies

Collaborating with retail chains, pharmacies, health food stores and e-commerce platforms expands market reach and enhances product accessibility. Strategic partnerships with healthcare professionals, wellness centers, or corporate wellness programs also facilitate product recommendation and distribution.

For instance, in 2021, Kerry partnered with Pharma Foods International Co. Ltd. (PFI) for the development, application and global sales of a joint health ingredient technology for functional foods and beverages and dietary supplements. Pharma Foods International, based in Kyoto, Japan, is a pioneer and leader in innovative ingredients developed from natural food origins for application into functional products, nutraceuticals, cosmetics and pharmaceuticals.

Additionally, in 2022, Kirin Holdings is expanding its functional food product lineup to increase immune care in Japan. In collaboration with external partner companies, Kirin Holdings will increase immune function claims and the number of products containing its exclusive postbiotic Lactococcus lactis strain Plasma Kirin Group introduced Kirin iMuse Immune Care Good Sleep Plus, a dual-care supplement for immunity and quality sleep.

Moreover, in 2023, Japanese drugmaker Otsuka Pharmaceutical acquired U.S. women's health food company Bonafide Health for $425 million, its parent Otsuka Holdings, to diversify its portfolio of women's supplements. Through this acquisition, Otsuka Pharmaceutical has been expanding its business of women's health supplements and other fields. These strategies collectively drive growth, expand market share and sustain competitive advantage for companies operating in Japan's food supplement market.

Market Restraints

Perceived Overconsumption Risks

Japanese consumers often consult healthcare professionals, such as doctors and pharmacists, for health advice and recommendations. Medical professionals may caution against excessive use of supplements, emphasizing the importance of obtaining nutrients from a balanced diet and lifestyle. This advice can influence consumer perceptions and decisions regarding supplement use.

There is a concern among some consumers and healthcare professionals about the potential risks of overconsumption of certain nutrients from supplements, which can lead to adverse health effects. This caution may influence consumer behavior and usage patterns. For instance, in 2024, Kobayashi Pharmaceutical, which has been selling dietary supplements and over-the-counter drugs, recalled the product after concerns were raised.

Japan issued a nationwide recall of a dietary supplement which was to lower the levels of cholesterol amid speculations that it could have led to two deaths and around 106 hospitalizations in the country. The company recalled five products including around 3,00,000 units of 'beni-koji choleste help', which was renowned for helping lower cholesterol.

Moreover, perceived risks of overconsumption restrain the food supplement market in Japan by influencing consumer attitudes, regulatory policies, healthcare advice and market dynamics. Overcoming these challenges requires building consumer trust through education, transparency and adherence to rigorous safety standards while emphasizing the complementary role of supplements in supporting overall health and well-being alongside a balanced diet. Thus above factors restrain market growth.

Market Segment Analysis

The Japan food supplement market is segmented based on ingredient, dosage, application, age and distribution channel.

Rising Demand for Anti/Healthy Ageing Drives the Segment Growth

The anti/healthy ageing segment is expected to dominate with over 11.29% of the market during the forecast period 2024-2027. The anti/healthy ageing segment is dominant in Japan's food supplements market primarily due to the country's rapidly aging population and cultural focus on longevity and wellness.

Japan has one of the world's oldest populations. This demographic shift drives demand for supplements that promote healthy aging, including products that support joint health, cognitive function and bone strength. For instance, according to figures released by the Ministry of Internal Affairs and Communications, the proportion of Japan's elderly, defined as age 65 and above, is also at a record high, comprising 29.1% of the population, the highest rate in the world.

Japan's healthcare system promotes regular health checkups and preventive care, which encourages older adults to actively seek supplements for managing age-related conditions. Products like omega-3 fatty acids for heart health and probiotics for gut health are widely consumed for their preventive benefits.

Many major companies are focusing on the anti-aging segment to launch innovative supplements in Japan. For instance, in January 2024, Shiseido said that they would be launching a new set of beauty-from-within supplements that comes in the form of ampoule drinks in Japan and China in 2024, senior vice president of the company's China Business Innovations and Investments announced the news.

Sustainability Analysis

Sustainability in Japan's food supplements market is increasingly important, driven by consumer demand for eco-friendly practices, regulatory pressure and corporate responsibility. Japanese consumers are gravitating toward supplements made from natural and organic ingredients. This aligns with Japan's broader cultural reverence for nature, reflected in the rising popularity of plant-based supplements, like those derived from green tea or seaweed.

Many Japanese supplement companies are adopting eco-friendly packaging solutions, reducing plastic use and opting for biodegradable materials. For instance, FANCL Corporation has introduced recyclable packaging for some of its supplement lines. The FANCL Recycling Program is an initiative that collects used containers from customers at stores nationwide. These containers are sorted, cleaned, dried and crushed by the special subsidiary FANCL SMILE and then recycled into flower pots by a partner recycling company using material recycling technology.

In addition, companies like Otsuka Pharmaceutical are taking steps to reduce their carbon footprint by using renewable energy in production processes and optimizing supply chain logistics to minimize environmental impact.

Japan's government encourages sustainable practices across industries. The introduction of policies promoting reduced emissions, waste management and sustainable agriculture directly impacts supplement manufacturers, pushing them toward greener production methods. Japan is increasingly supporting circular economy practices, which involve recycling and reusing materials within the supply chain.

Unmet Needs

Consumer trust in supplements hinges on transparent and evidence-based health claims. Despite stringent regulatory frameworks, more robust clinical trials and research studies are needed to validate supplement ingredients' efficacy and safety. This gap presents an opportunity for companies to invest in rigorous scientific research to substantiate health claims, particularly for emerging ingredients like botanical extracts and novel formulations.

With increasing consumer awareness of environmental sustainability and ethical sourcing practices, there is a growing demand for supplements derived from sustainably sourced ingredients. There is an opportunity for brands to differentiate themselves by adopting transparent supply chain practices, eco-friendly packaging and supporting ethical farming practices. Addressing these concerns could enhance brand credibility and appeal to environmentally conscious consumers.

As consumer awareness grows around specific health concerns such as stress management, immune support and digestive health, there is an opportunity for supplements that offer targeted health solutions with clear benefits. Innovations in ingredient combinations and delivery systems could address these unmet needs, providing effective and scientifically validated solutions to common health challenges.

Despite the widespread availability of supplements, there remains a need for nutrient-dense formulations that provide comprehensive nutritional support in a convenient format. Products that combine vitamins, minerals, antioxidants and phytonutrients in balanced proportions could meet the demand for holistic health solutions, catering to busy lifestyles and diverse dietary preferences.

Market Competitive Landscape

The major global players in the Japan market include Yotsuba Japan, DHC Corporation, Yazuya Co. Ltd., Asahi Group Foods, Ltd., FANCL Corporation, YUWA CO., LTD., Meiji Holdings Co., Ltd., MORINAGA MILK INDUSTRY CO., LTD., Nihon kefir Co., Ltd., ORIHIRO Co., Ltd. and among others.

By Ingredient

Vitamins

Botanicals

Minerals

Protein & Amino Acids

Omega Fatty Acids

Probiotics

Others

By Dosage

Tablet

Capsules

Liquid

Powder

Chewables & Gummies

Soft Gels

Others

By Application

Gastrointestinal Health

Gut Microbiota/Microbiome Balance

Digestion

Constipation

Bloating

Diarrhea

Leaky Gut

Inflammation

Others

Gluten sensitivity

Abdominal Pain

GERD/Helicobacter Pylori

Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment

Gut Flora/Gut Microbiome Restoration

Others

Vaginal Health

Urinary Tract Health

Kidney Stones

UTIs

Others

Oral Health

Anti/Healthy Ageing

Allergies/Asthma

Bone & Joint Health

Osteoarthritis

Osteoporosis/Low Mineral Bone Density

Inflammation

Brain/Mental Health

Sleep

Cognition

Mood

Depression

Focus

Cardiovascular Health

Circulation

Energy/Fatigue Reduction

Metabolic Syndrome/Blood Glucose

Liver Health

Energy

Immunity/Respiratory Infections

Nutrient Absorption

Skin-Hair-Nails

Atopic Dermatitis & Eczema

Acne

Rosacea

Hair Growth/Hair Loss

Skin Microbiome

Others

Sports

Women's Health

Fertility

Menopause

Pregnancy

PCOS

Vaginal Health & Health Vaginal Microbiome

Vaginal Infections (BV/VVC)

Pregnancy Outcomes

Others

Men's Health & Men's Fertility

Weight Management

Pediatric Health

Colic

Constipation

Regurgitation

Atopic Dermatitis

Others

Others

By Age

Infant

Children

Adults

Seniors

By Distribution Channel

Supermarkets/Hypermarkets

Pharmacies and Drug Stores

Convenience Stores

Online Retailers

Other Distribution Channels

Key Developments

In May 2024, Japanese wellness firm natural tech Co Ltd released a new eye supplement amid 'skyrocketing demand' and said that lifestyle changes of modern consumers and the country's aging population have led to increasing eye-related problems, which it aims to address with its new supplement.

In May 2023, Japanese firm DyDo DRINCO intends to delve further into the health foods category targeted at the aged population, following the launch of its dual-action supplement that it says helps reduce eye fatigue and improve sleep quality.

In July 2021, Ajinomoto launched a supplement, backed by a clinical trial, to reduce the risk of cognitive decline in healthy middle-aged persons and elderly experiencing some form of memory impairment.

In November 2021, Otsuka Pharmaceutical Co., Ltd. launched tocoelle, a supplement to support women bothered by pre-menstrual fluctuations. This supplement delivers four important components: vitamin E (Y-tocopherol and Y-tocotrienol) contained in soy oil; equol, produced from soy isoflavones; and calcium, a mineral often lacking in daily diets.

Why Purchase the Report?

To visualize the Japan food supplement market segmentation based on ingredient, dosage, application, age and distribution channel, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of Japan food supplement market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The Japan food supplement market report would provide approximately 45 tables, 62 figures and 204 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Ingredient
• 3.2. Snippet by Dosage
• 3.3. Snippet by Application
• 3.4. Snippet by Age
• 3.5. Snippet by Distribution Channel

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The Rise of Nutritional Deficiencies
    • 4.1.1.2. Strategies Adopted by the Companies
  • 4.1.2. Restraints
    • 4.1.2.1. Perceived Overconsumption Risks
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. By Ingredient

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  • 6.1.2. Market Attractiveness Index, By Ingredient
• 6.2. Vitamins*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Botanicals
• 6.4. Minerals
• 6.5. Protein & Amino Acids
• 6.6. Omega Fatty Acids
• 6.7. Probiotics
• 6.8. Others

7. By Dosage

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
  • 7.1.2. Market Attractiveness Index, By Dosage
• 7.2. Tablet*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Capsules
• 7.4. Liquid
• 7.5. Powder
• 7.6. Others

8. Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Gastrointestinal Health*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.2.3. Gut Microbiota/Microbiome Balance
  • 8.2.4. Digestion
  • 8.2.5. Constipation
  • 8.2.6. Bloating
  • 8.2.7. Diarrhea
  • 8.2.8. Leaky Gut
  • 8.2.9. Inflammation
  • 8.2.10. Others
    • 8.2.10.1. Gluten sensitivity
    • 8.2.10.2. Abdominal Pain
    • 8.2.10.3. GERD/Helicobacter pylori
    • 8.2.10.4. Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
    • 8.2.10.5. Gut Flora/Gut Microbiome Restoration
    • 8.2.10.6. Others
• 8.3. Vaginal Health
• 8.4. Urinary Tract Health
  • 8.4.1. Kidney Stones
  • 8.4.2. UTIs
  • 8.4.3. Others
• 8.5. Oral Health
• 8.6. Anti/Healthy Ageing
• 8.7. Allergies/Asthma
• 8.8. Bone & Joint Health
  • 8.8.1. Osteoarthritis
  • 8.8.2. Osteoporosis/Low Mineral Bone Density
  • 8.8.3. Inflammation
• 8.9. Brain/Mental Health
  • 8.9.1. Sleep
  • 8.9.2. Cognition
  • 8.9.3. Mood
  • 8.9.4. Depression
  • 8.9.5. Focus
• 8.10. Cardiovascular Health
• 8.11. Circulation
• 8.12. Energy/Fatigue Reduction
• 8.13. Metabolic Syndrome/Blood Glucose
• 8.14. Liver Health
• 8.15. Energy
• 8.16. Immunity/Respiratory Infections
• 8.17. Nutrient Absorption
• 8.18. Skin-Hair-Nails
  • 8.18.1. Atopic Dermatitis & Eczema
  • 8.18.2. Acne
  • 8.18.3. Rosacea
  • 8.18.4. Hair Growth/Hair Loss
  • 8.18.5. Skin Microbiome
  • 8.18.6. Others
• 8.19. Sports
• 8.20. Women's Health
  • 8.20.1. Fertility
  • 8.20.2. Menopause
  • 8.20.3. Pregnancy
  • 8.20.4. PCOS
  • 8.20.5. Vaginal Health & Health Vaginal Microbiome
  • 8.20.6. Vaginal Infections (BV/VVC)
  • 8.20.7. Pregnancy Outcomes
  • 8.20.8. Others
• 8.21. Men's Health & Men's Fertility
• 8.22. Weight Management
• 8.23. Pediatric Health
  • 8.23.1. Colic
  • 8.23.2. Constipation
  • 8.23.3. Regurgitation
  • 8.23.4. Atopic Dermatitis
  • 8.23.5. Others
• 8.24. Others

9. Age

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
  • 9.1.2. Market Attractiveness Index, By Age
• 9.2. Infant*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Children
• 9.4. Adults
• 9.5. Seniors

10. Distribution Channel

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.1.2. Market Attractiveness Index, By Distribution Channel
• 10.2. Supermarkets/Hypermarkets*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Pharmacies and Drug Stores
• 10.4. Convenience Stores
• 10.5. Online Retailers
• 10.6. Other Distribution Channels

11. Sustainability Analysis

• 11.1. Environmental Analysis
• 11.2. Economic Analysis
• 11.3. Governance Analysis

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. Yotsuba Japan*
  • 13.1.1. Company Overview
  • 13.1.2. Type Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. DHC Corporation
• 13.3. Yazuya Co. Ltd.
• 13.4. Asahi Group Foods, Ltd.
• 13.5. FANCL Corporation
• 13.6. YUWA CO., LTD.
• 13.7. Meiji Holdings Co., Ltd.
• 13.8. MORINAGA MILK INDUSTRY CO., LTD.
• 13.9. Nihon kefir Co., Ltd.
• 13.10. ORIHIRO Co., Ltd. (*LIST NOT EXHAUSTIVE)

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us